vs

Side-by-side financial comparison of Reservoir Media, Inc. (RSVR) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $45.6M, roughly 1.3× Reservoir Media, Inc.). Reservoir Media, Inc. runs the higher net margin — 4.8% vs -83.0%, a 87.8% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 7.7%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 7.9%).

Reservoir Media, Inc. is a leading global independent music rights management company. It owns and administers extensive catalogs of recorded music, music publishing copyrights, and neighboring rights, partnering with top songwriters, performing artists, and producers across genres including pop, hip-hop, rock, and film soundtracks. It licenses its content for use across streaming platforms, advertising, film and television productions, live events, and other commercial channels, with operations spanning North America, Europe, and Asia Pacific markets.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

RSVR vs RYTM — Head-to-Head

Bigger by revenue
RYTM
RYTM
1.3× larger
RYTM
$57.3M
$45.6M
RSVR
Growing faster (revenue YoY)
RYTM
RYTM
+29.2% gap
RYTM
36.9%
7.7%
RSVR
Higher net margin
RSVR
RSVR
87.8% more per $
RSVR
4.8%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
7.9%
RSVR

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
RSVR
RSVR
RYTM
RYTM
Revenue
$45.6M
$57.3M
Net Profit
$2.2M
$-47.5M
Gross Margin
64.5%
91.6%
Operating Margin
22.7%
-82.2%
Net Margin
4.8%
-83.0%
Revenue YoY
7.7%
36.9%
Net Profit YoY
-58.1%
-9.6%
EPS (diluted)
$0.03
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RSVR
RSVR
RYTM
RYTM
Q4 25
$45.6M
$57.3M
Q3 25
$45.4M
$51.3M
Q2 25
$37.2M
$48.5M
Q1 25
$41.4M
$32.7M
Q4 24
$42.3M
$41.8M
Q3 24
$40.7M
$33.3M
Q2 24
$34.3M
$29.1M
Q1 24
$39.1M
$26.0M
Net Profit
RSVR
RSVR
RYTM
RYTM
Q4 25
$2.2M
$-47.5M
Q3 25
$2.3M
$-52.9M
Q2 25
$-555.7K
$-46.6M
Q1 25
$2.7M
$-49.5M
Q4 24
$5.2M
$-43.3M
Q3 24
$185.0K
$-43.6M
Q2 24
$-346.7K
$-32.3M
Q1 24
$2.8M
$-141.4M
Gross Margin
RSVR
RSVR
RYTM
RYTM
Q4 25
64.5%
91.6%
Q3 25
63.6%
89.3%
Q2 25
64.5%
88.6%
Q1 25
65.6%
88.8%
Q4 24
64.4%
90.9%
Q3 24
63.5%
88.5%
Q2 24
61.3%
89.9%
Q1 24
63.4%
89.2%
Operating Margin
RSVR
RSVR
RYTM
RYTM
Q4 25
22.7%
-82.2%
Q3 25
23.5%
-102.6%
Q2 25
14.7%
-93.4%
Q1 25
25.2%
-143.7%
Q4 24
22.6%
-98.6%
Q3 24
24.9%
-132.0%
Q2 24
14.5%
-139.2%
Q1 24
22.4%
-538.7%
Net Margin
RSVR
RSVR
RYTM
RYTM
Q4 25
4.8%
-83.0%
Q3 25
5.0%
-103.1%
Q2 25
-1.5%
-96.1%
Q1 25
6.4%
-151.4%
Q4 24
12.4%
-103.6%
Q3 24
0.5%
-131.2%
Q2 24
-1.0%
-110.9%
Q1 24
7.1%
-544.4%
EPS (diluted)
RSVR
RSVR
RYTM
RYTM
Q4 25
$0.03
$-0.73
Q3 25
$0.03
$-0.82
Q2 25
$-0.01
$-0.75
Q1 25
$-0.81
Q4 24
$0.08
$-0.71
Q3 24
$-0.73
Q2 24
$-0.01
$-0.55
Q1 24
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RSVR
RSVR
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$20.6M
$388.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$373.6M
$139.1M
Total Assets
$941.9M
$480.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RSVR
RSVR
RYTM
RYTM
Q4 25
$20.6M
$388.9M
Q3 25
$27.9M
$416.1M
Q2 25
$14.9M
$291.0M
Q1 25
$21.4M
$314.5M
Q4 24
$17.8M
$320.6M
Q3 24
$21.1M
$298.4M
Q2 24
$16.4M
$319.1M
Q1 24
$18.1M
$201.2M
Stockholders' Equity
RSVR
RSVR
RYTM
RYTM
Q4 25
$373.6M
$139.1M
Q3 25
$370.9M
$148.8M
Q2 25
$368.9M
$-11.9M
Q1 25
$364.9M
$18.9M
Q4 24
$359.5M
$21.7M
Q3 24
$357.9M
$11.2M
Q2 24
$353.0M
$39.3M
Q1 24
$353.0M
$61.6M
Total Assets
RSVR
RSVR
RYTM
RYTM
Q4 25
$941.9M
$480.2M
Q3 25
$903.5M
$506.9M
Q2 25
$857.0M
$372.7M
Q1 25
$865.1M
$386.7M
Q4 24
$832.4M
$392.3M
Q3 24
$778.2M
$363.6M
Q2 24
$768.2M
$381.8M
Q1 24
$783.5M
$258.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RSVR
RSVR
RYTM
RYTM
Operating Cash FlowLast quarter
$12.9M
$-25.4M
Free Cash FlowOCF − Capex
$12.8M
FCF MarginFCF / Revenue
28.1%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
5.89×
TTM Free Cash FlowTrailing 4 quarters
$50.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RSVR
RSVR
RYTM
RYTM
Q4 25
$12.9M
$-25.4M
Q3 25
$19.3M
$-26.6M
Q2 25
$6.0M
$-23.3M
Q1 25
$12.2M
$-40.4M
Q4 24
$11.2M
$-18.8M
Q3 24
$13.3M
$-25.2M
Q2 24
$8.6M
$-29.1M
Q1 24
$13.8M
$-40.7M
Free Cash Flow
RSVR
RSVR
RYTM
RYTM
Q4 25
$12.8M
Q3 25
$19.2M
Q2 25
$6.0M
Q1 25
$12.2M
Q4 24
$11.2M
Q3 24
$13.3M
Q2 24
$8.5M
Q1 24
$13.8M
FCF Margin
RSVR
RSVR
RYTM
RYTM
Q4 25
28.1%
Q3 25
42.2%
Q2 25
16.1%
Q1 25
29.3%
Q4 24
26.5%
Q3 24
32.7%
Q2 24
24.9%
Q1 24
35.2%
Capex Intensity
RSVR
RSVR
RYTM
RYTM
Q4 25
0.3%
Q3 25
0.3%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.0%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.0%
Cash Conversion
RSVR
RSVR
RYTM
RYTM
Q4 25
5.89×
Q3 25
8.54×
Q2 25
Q1 25
4.56×
Q4 24
2.14×
Q3 24
71.97×
Q2 24
Q1 24
4.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RSVR
RSVR

Other$18.9M42%
Recorded Music Segment$12.9M28%
Performance$6.2M14%
Synchronization$4.6M10%
Physical$1.9M4%
Neighboring Rights$1.1M3%

RYTM
RYTM

Segment breakdown not available.

Related Comparisons